Merck, Moderna detail potential skin cancer vaccine progress

Corporate businessmen working on tablet at office

Shares of Merck and Moderna jumped Tuesday after the drugmakers said a potential skin cancer vaccine they are developing using the same technology behind COVID-19 preventive shots fared well in a small study.

Aubrey Plaza has *thoughts* on what really happened with Harper in ‘The White Lotus’

Previous article

Drinking coffee regularly after pregnancy may lower type 2 diabetes risk for women who had diabetes during pregnancy

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations